Skip to main content

Travere Therapeutics, Inc.

TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001438533

In the last 90 days, Travere Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.98B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Travere Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
9 insiders, $67.0M in total
Insiders trading
9
Net value
−$67.0M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Travere Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Travere Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Rote William E.Chief Research Officer98,197Sep 17, 20266
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER117,066Sep 17, 20267
Inrig JulaEVP, Head of R&D & CMO100,491Sep 17, 20268
Reed Elizabeth EChief Legal Officer and GC105,389Sep 17, 20269
Dube Eric MCHIEF EXECUTIVE OFFICER432,886Sep 17, 20268
Cline Christopher R.CHIEF FINANCIAL OFFICER87,508Sep 17, 20267
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER42,353Sep 17, 20266
Meckler Jeffrey ADirector91,500Sep 11, 20263
Lyons Gary ADirector61,500Aug 19, 20263
Coughlin TimothyDirector56,250Jun 16, 20264
Baynes Roy D.Director41,500Jun 16, 20266
Brinkley Ruth WilliamsDirector29,750May 21, 20261
Squarer RonDirector39,375May 21, 20261
Orwin John ADirector39,375May 21, 20261
Bruhn Suzanne LouiseDirector32,750May 21, 20261
Poole SandraDirector34,000May 21, 20261
Aselage SteveDirector146,919May 12, 20220
Clague LauraChief Financial Officer35,655May 12, 20220
Rosenberg Noah L.Chief Medical Officer47,614Aug 17, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 4, 2025 (view filing)Feb 31 dayReed Elizabeth ESVP, GC & CORPORATE SECRETARYSSale−8.95K$19.78−$177.1K−9.1%89.5K after10b5-1
Feb 4, 2025 (view filing)Feb 31 dayRote William E.SENIOR VICE PRESIDENT, R&DSSale−8.95K$19.78−$177.1K−8.6%95.7K after10b5-1
Feb 10, 2025 (view filing)Feb 64 daysBaynes Roy D.DirectorSSale−10.0K$22.00−$220.0K−24.4%31.0K after10b5-1
Feb 12, 2025 (view filing)Feb 12Same dayInrig JulaCHIEF MEDICAL OFFICERSSale−2.57K$23.53−$60.4K−2.8%89.6K after
Feb 12, 2025 (view filing)Feb 111 dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−11.4K$24.04−$273.5K−2.6%419.2K after10b5-1
Feb 12, 2025 (view filing)Feb 11-121 dayHeerma PeterCHIEF COMMERCIAL OFFICERSSale−5.64K$24.33−$137.3K−4.3%125.1K after2 lots10b5-1
Feb 12, 2025 (view filing)Feb 111 dayCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−54.2K$25.00−$1.36M−49.9%54.4K after5 lots10b5-1
Feb 12, 2025 (view filing)Feb 12Same dayReed Elizabeth ESVP, GC & CORPORATE SECRETARYSSale−8.00K$23.53−$188.2K−8.2%89.5K after10b5-1
Feb 12, 2025 (view filing)Feb 12Same dayRote William E.SENIOR VICE PRESIDENT, R&DSSale−5.20K$23.53−$122.4K−5.0%98.5K after10b5-1
Apr 14, 2025 (view filing)Apr 113 daysCline Christopher R.CHIEF FINANCIAL OFFICERSSale−48$13.14−$630.72−0.1%90.0K after
May 5, 2025 (view filing)May 5Same dayReed Elizabeth EChief Legal Officer and GCSSale−4.92K$21.05−$103.6K−5.2%89.5K after10b5-1
May 5, 2025 (view filing)May 5Same dayRote William E.Chief Research OfficerSSale−3.20K$21.05−$67.3K−3.1%100.2K after10b5-1
May 5, 2025 (view filing)May 5Same dayHeerma PeterCHIEF COMMERCIAL OFFICERSSale−1.77K$21.05−$37.3K−1.4%128.2K after
May 5, 2025 (view filing)May 5Same dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−18.9K$21.05−$398.4K−4.3%419.2K after10b5-1
May 5, 2025 (view filing)May 5Same dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−1.78K$21.05−$37.6K−1.9%93.1K after
Jul 2, 2025 (view filing)Jul 11 dayInrig JulaCHIEF MEDICAL OFFICERSSale−815$14.65−$11.9K−0.9%88.8K after10b5-1
Aug 28, 2025 (view filing)Aug 271 dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−470$17.31−$8.14K−0.5%92.7K after10b5-1
Sep 5, 2025 (view filing)Sep 3-42 daysCline Christopher R.CHIEF FINANCIAL OFFICERSSale−573$18.51−$10.6K−0.6%92.1K after2 lots10b5-1
Sep 24, 2025 (view filing)Sep 222 daysReed Elizabeth EChief Legal Officer and GCSSale−10.0K$25.00−$250.0K−10.0%89.9K after10b5-1
Oct 30, 2025 (view filing)Oct 28-292 daysDube Eric MCHIEF EXECUTIVE OFFICERSSale−120.0K$30.32−$3.64M−22.3%419.2K after2 lots10b5-1
Oct 30, 2025 (view filing)Oct 282 daysHeerma PeterCHIEF COMMERCIAL OFFICERSSale−2.66K$30.00−$79.9K−2.1%124.7K after10b5-1
Nov 4, 2025 (view filing)Oct 314 daysCoughlin TimothyDirectorSSale−18.0K$35.03−$630.5K−24.5%55.5K after10b5-1
Nov 4, 2025 (view filing)Oct 314 daysHeerma PeterCHIEF COMMERCIAL OFFICERSSale−5.59K$35.00−$195.7K−4.5%119.1K after10b5-1
Nov 6, 2025 (view filing)Nov 42 daysCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−67.1K$36.00−$2.42M−58.0%48.5K after10b5-1
Dec 3, 2025 (view filing)Dec 12 daysCline Christopher R.CHIEF FINANCIAL OFFICERSSale−20.0K$35.01−$700.2K−17.8%92.1K after10b5-1
Dec 16, 2025 (view filing)Dec 151 dayCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−2.91K$36.00−$104.8K−6.0%45.6K after10b5-1
Dec 29, 2025 (view filing)Dec 245 daysRote William E.Chief Research OfficerSSale−60.0K$40.10−$2.41M−37.2%101.4K after10b5-1
Dec 29, 2025 (view filing)Dec 245 daysHeerma PeterCHIEF COMMERCIAL OFFICERSSale−4.98K$40.00−$199.2K−4.2%113.0K after10b5-1
Dec 29, 2025 (view filing)Dec 245 daysCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−7.40K$40.00−$296.1K−16.2%38.2K after10b5-1
Dec 29, 2025 (view filing)Dec 245 daysInrig JulaCHIEF MEDICAL OFFICERSSale−15.0K$42.00−$630.0K−14.5%88.8K after10b5-1
Jan 7, 2026 (view filing)Jan 5-62 daysInrig JulaCHIEF MEDICAL OFFICERSSale−2.48K$39.74−$98.4K−2.8%86.3K after2 lots10b5-1
Jan 21, 2026 (view filing)Jan 201 dayReed Elizabeth EChief Legal Officer and GCSSale−10.0K$27.34−$273.4K−10.0%90.3K after10b5-1
Jan 27, 2026 (view filing)Jan 23-274 daysDube Eric MCHIEF EXECUTIVE OFFICERSSale−60.0K$30.09−$1.81M−12.5%419.2K after2 lots10b5-1
Feb 3, 2026 (view filing)Feb 3Same dayReed Elizabeth EChief Legal Officer and GCSSale−7.17K$32.12−$230.5K−6.2%108.2K after
Feb 3, 2026 (view filing)Feb 3Same dayRote William E.Chief Research OfficerSSale−12.4K$32.87−$409.1K−10.2%109.1K after10b5-1
Feb 3, 2026 (view filing)Feb 3Same dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−100.1K$32.28−$3.23M−18.8%432.9K after2 lots10b5-1
Feb 3, 2026 (view filing)Feb 3Same dayHeerma PeterCHIEF COMMERCIAL OFFICERSSale−7.31K$32.12−$234.8K−5.3%131.8K after
Feb 3, 2026 (view filing)Feb 3Same dayCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−4.33K$32.12−$139.2K−8.1%49.1K after
Feb 3, 2026 (view filing)Feb 3Same dayInrig JulaCHIEF MEDICAL OFFICERSSale−6.96K$32.12−$223.4K−6.1%107.5K after
Feb 3, 2026 (view filing)Feb 3Same dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−7.24K$32.12−$232.6K−6.0%113.0K after
Feb 5, 2026 (view filing)Feb 41 dayReed Elizabeth EChief Legal Officer and GCSSale−2.99K$32.18−$96.4K−2.8%105.2K after2 lots10b5-1
Feb 5, 2026 (view filing)Feb 41 dayInrig JulaCHIEF MEDICAL OFFICERSSale−1.78K$32.21−$57.3K−1.7%105.7K after2 lots10b5-1
Feb 5, 2026 (view filing)Feb 41 dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−1.75K$32.19−$56.2K−1.5%111.2K after2 lots10b5-1
Feb 19, 2026 (view filing)Feb 172 daysReed Elizabeth EChief Legal Officer and GCSSale−10.0K$27.83−$278.3K−8.7%105.2K after2 lots10b5-1
Feb 24, 2026 (view filing)Feb 204 daysDube Eric MCHIEF EXECUTIVE OFFICERSSale−60.0K$30.10−$1.81M−12.2%432.9K after10b5-1
Mar 18, 2026 (view filing)Mar 162 daysReed Elizabeth EChief Legal Officer and GCSSale−10.0K$28.09−$280.9K−8.7%105.2K after10b5-1
Apr 2, 2026 (view filing)Apr 11 dayReed Elizabeth EChief Legal Officer and GCSSale−10.0K$30.00−$300.0K−8.7%105.2K after10b5-1
Apr 2, 2026 (view filing)Apr 11 dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−60.0K$30.93−$1.86M−12.2%432.9K after2 lots10b5-1
Apr 7, 2026 (view filing)Apr 61 dayBaynes Roy D.DirectorSSale−10.0K$33.00−$330.0K−21.1%37.5K after10b5-1
Apr 15, 2026 (view filing)Apr 14-151 dayReed Elizabeth EChief Legal Officer and GCSSale−51.5K$41.29−$2.13M−32.9%105.2K after4 lots10b5-1